UCB Recognized as a Top Workplace in Metro Atlanta for 2026 by Axios

UCB Honored as a Top Workplace in Metro Atlanta for 2026

UCB, a prominent global biopharmaceutical entity, has recently garnered the 2026 Metro Atlanta Top Workplaces Award, as announced by Axios. This recognition not only highlights UCB's dedication to fostering an engaging work environment but also underscores the company's expansive growth within the region. As part of a massive $2 billion investment plan to establish a state-of-the-art biomanufacturing campus in Gwinnett County, UCB is poised to generate over 330 new jobs, signifying a substantial boost to the local economy.

UCB has proudly maintained its U.S. headquarters in Atlanta for over three decades, employing more than 400 dedicated individuals. This latest accolade reinforces the firm's strategic commitment to Georgia, where its workforce continues to grow alongside its innovative life sciences initiatives. Taco van Tiel, the Head of UCB in the U.S., expressed the significance of this honor, stating, "This recognition is especially meaningful because it reflects the voices and experiences of our people. As UCB continues to invest in Georgia, including through our planned U.S. biologics manufacturing site, our ability to attract and support top talent will be central to delivering on our purpose for patients. We are proud to be part of the metro Atlanta community and to continue building a workplace where employees feel empowered to contribute, grow, and make an impact."

The Significance of Employee Feedback

The Top Workplaces award is uniquely notable because it is based entirely on anonymous feedback collected from employees through a third-party survey conducted by Energage. In a competitive landscape where fewer than 60 organizations were recognized, this award highlights UCB's proactive initiatives towards employee satisfaction and growth. UCB previously won this accolade in 2021, showcasing its consistent commitment to fostering a positive workplace culture. Michele Ehler, UCB's Head of U.S. Talent, commented, "Creating an environment where talented people can do their best work is fundamental to our success at UCB. This recognition reflects the culture our employees have helped build, one rooted in collaboration, growth, and a shared commitment to improving the lives of people living with severe diseases."

A Vision for the Future

UCB's strategic focus on Georgia is not merely about expanding its operational footprint, but also embodies its long-term vision for growth and innovation within the biopharmaceutical sector. The planned biomanufacturing campus will not only produce essential medicines but is also expected to impact the regional economy substantially, generating approximately $5 billion in economic activity. Such initiatives demonstrate UCB’s commitment to supporting local communities while simultaneously advancing its mission to provide high-quality treatments for patients in need.

In addition to its operational advancements, UCB continues to prioritize the development of a workforce that is engaged and motivated. Investing in employee growth and satisfaction is seen as essential in connecting UCB’s mission with day-to-day operations. The firm recognizes that a robust, skilled workforce is the backbone of a successful biopharmaceutical company, particularly as UCB strives toward delivering innovative treatments for severe diseases.

As UCB charts its course into the future with its expanding workforce and growing reputation, the company’s leadership remains dedicated to creating a supportive and dynamic environment for all employees. UCB’s commitment to investing in its people not only fortifies its position as a top workplace but also sets a standard for excellence in the biopharmaceutical industry.

For more information on UCB and its initiatives, visit their official website at ucb.com.